|
Conference:
|
Human Amyloid Imaging 2012
|
|
Description:
|
At HAI 2012 we will continue to emphasize ample lively discussion of core controversies such as: what does the presence of brain amyloid mean, how should it be measured, how does it change, and what does it portend? Our discussions will again primarily spring from brief presentations by active investigators who will report unpublished, cutting-edge research in human imaging of amyloid-β and/or other biomarkers that pertain to Alzheimer's-related disease. To assemble at HAI only the most recent, important work, abstract submissions will again be accepted and peer-reviewed less than two months prior to the meeting. We expect again this year to have presenters from approximately 20 research groups from the US, Europe, UK, Japan, South Korea, and Australia.
|
Home
From basic clinical research to case studies. 
Check out our latest Webinar: 
